Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Precision Biosciences Inc
(NQ:
DTIL
)
9.655
-0.285 (-2.87%)
Streaming Delayed Price
Updated: 12:49 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Precision Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Precision BioSciences Q4 Earnings
March 15, 2022
Precision BioSciences (NASDAQ:DTIL) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
March 15, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Preview: Precision BioSciences's Earnings
March 14, 2022
Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement....
Via
Benzinga
Earnings Scheduled For March 15, 2022
March 15, 2022
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...
Via
Benzinga
Precision BioSciences to Present at the 40th Annual J.P. Morgan Health Care Conference
January 04, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
Precision BioSciences Completes Spin-Out of Elo Life Systems
December 21, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
Precision BioSciences Reports Clinical Program Updates for Its Allogeneic CAR T Pipeline
December 11, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021
December 06, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Present Preclinical Gene Editing Data on its ARCUS-Based Chronic Hepatitis B Program at the HEP DART 2021 Conference
December 03, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
November 18, 2021
Gainers NeuroOne Medical Tech (NASDAQ:NMTC...
Via
Benzinga
Precision BioSciences Earnings Perspective: Return On Capital Employed
November 11, 2021
Benzinga Pro data, Precision BioSciences (NASDAQ:DTIL) reported Q3 sales of $24.04 million. Earnings fell to a loss of $11.27 million, resulting in a 152.09% decrease from last...
Via
Benzinga
Precision BioSciences Reports Third Quarter 2021 Financial Results and Provides Business Update
November 10, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Earnings Preview
November 09, 2021
Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement....
Via
Benzinga
Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual Meeting
November 09, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Appoints Sam Wadsworth, Ph.D. and Shari Lisa Piré, J.D. to Board of Directors
November 08, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy for Relapsed and Refractory B-cell Malignancies at the 63rd Annual Meeting of the American Society of Hematology
November 04, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report Third Quarter 2021 Financial Results on November 10, 2021 and Participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021
November 03, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Present at the Jefferies Virtual Gene Therapy/Editing Summit on Thursday, October 27, 2021
October 21, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19...
Via
Benzinga
Precision BioSciences Announces Grant of Inducement Award for Newly Appointed Chief Executive Officer Pursuant to Nasdaq Listing Rule 5635(c)(4)
September 27, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Appoints Michael Amoroso Chief Executive Officer
September 27, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 10, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences, iECURE Ink Licensing Pact For Gene Editing Therapies
September 09, 2021
Precision BioSciences Inc (NASDAQ: DTIL) and iECURE announced a license and collaboration agreement. Under the agreement iECURE plans to advance Precision's PBGENE-...
Via
Benzinga
Precision BioSciences Outlines Clinical Development Strategy for In Vivo Gene Editing Pipeline
September 09, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
Precision BioSciences and iECURE Announce License and Collaboration Agreement to Develop ARCUS-Based Gene Editing Therapies
September 09, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.